|
US3480613A
(en)
|
1967-07-03 |
1969-11-25 |
Merck & Co Inc |
2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
|
|
US3817978A
(en)
|
1971-06-16 |
1974-06-18 |
Syntex Inc |
4-fluoro nucleosides and sugar intermediates, and methods of preparing
|
|
US3852267A
(en)
|
1972-08-04 |
1974-12-03 |
Icn Pharmaceuticals |
Phosphoramidates of 3{40 ,5{40 -cyclic purine nucleotides
|
|
DE3239986A1
(de)
|
1982-10-28 |
1984-05-03 |
Robert Bosch Gmbh, 7000 Stuttgart |
Handwerkzeugmaschine mit einem kreisscheibenfoermigen werkzeug
|
|
US4713383A
(en)
|
1984-10-01 |
1987-12-15 |
Ciba-Geigy Corporation |
Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
|
|
US5698390A
(en)
|
1987-11-18 |
1997-12-16 |
Chiron Corporation |
Hepatitis C immunoassays
|
|
US6171782B1
(en)
|
1987-11-18 |
2001-01-09 |
Chiron Corporation |
Antibody compositions to HCV and uses thereof
|
|
US5679342A
(en)
|
1987-11-18 |
1997-10-21 |
Chiron Corporation |
Hepatitis C virus infected cell systems
|
|
US5712088A
(en)
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
|
US5714596A
(en)
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
|
IN167775B
(es)
|
1988-06-24 |
1990-12-22 |
Hoechst India |
|
|
US6027729A
(en)
|
1989-04-20 |
2000-02-22 |
Chiron Corporation |
NANBV Diagnostics and vaccines
|
|
US5049551A
(en)
|
1989-05-30 |
1991-09-17 |
Ube Industries, Ltd. |
5-fluorouracil, 2'-deoxy-5-fluorouridine and 1-carbomoyl-5-fluorouracil compounds
|
|
DE3932052A1
(de)
|
1989-09-26 |
1991-04-04 |
Basf Ag |
Oxazol- bzw. thiazolcarbonsaeureamide
|
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
|
JP2889408B2
(ja)
|
1991-09-17 |
1999-05-10 |
富士写真フイルム株式会社 |
アゾメチン化合物及びこれを含有する熱転写色素供与材料
|
|
GB9202791D0
(en)
|
1992-02-11 |
1992-03-25 |
British Bio Technology |
Compounds
|
|
DE4207363A1
(de)
|
1992-03-04 |
1993-09-09 |
Max Delbrueck Centrum |
Antivirale nucleosidanaloga, ihre herstellung und ihre pharmazeutische verwendung
|
|
AU729657B2
(en)
|
1992-05-11 |
2001-02-08 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for inhibiting viral replication
|
|
US6174868B1
(en)
|
1992-09-10 |
2001-01-16 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of hepatitis C virus-associated diseases
|
|
US6995146B2
(en)
|
1992-09-10 |
2006-02-07 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of hepatitis C virus-associated diseases
|
|
US6391542B1
(en)
|
1992-09-10 |
2002-05-21 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus-associated diseases
|
|
US6423489B1
(en)
|
1992-09-10 |
2002-07-23 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus-associated diseases
|
|
US6433159B1
(en)
|
1992-09-10 |
2002-08-13 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus associated diseases
|
|
ATE202383T1
(de)
|
1992-09-10 |
2001-07-15 |
Isis Pharmaceuticals Inc |
Zusammensetzungen und verfahren für die behandlung von mit hepatitis c viren assoziierten krankheiten
|
|
DE4232852A1
(de)
|
1992-09-30 |
1994-03-31 |
Bayer Ag |
Imidazolinyl-pyridazine
|
|
ZA943999B
(en)
|
1993-06-09 |
1995-02-03 |
Lonza Ag |
Quaternary ammonium and waterproofing/preservative compositions
|
|
WO1995008540A1
(en)
|
1993-09-22 |
1995-03-30 |
The Wellcome Foundation Limited |
Bis(amidinobenzimidazolyl)alkanes as antiviral agents
|
|
DE4341161A1
(de)
|
1993-12-02 |
1995-06-08 |
Michael Prof Dr Zeppezauer |
Membrangängiger Wirkstoff zur Störung der DNA-Biosynthese
|
|
JPH07242544A
(ja)
|
1994-03-01 |
1995-09-19 |
Takeda Chem Ind Ltd |
抗腫瘍剤
|
|
GB9505025D0
(en)
|
1995-03-13 |
1995-05-03 |
Medical Res Council |
Chemical compounds
|
|
CZ293584B6
(cs)
|
1996-01-23 |
2004-06-16 |
Icn Pharmaceuticals |
Prostředek pro modulaci exprese lymfokinů
|
|
AU727177B2
(en)
|
1996-10-16 |
2000-12-07 |
Icn Pharmaceuticals, Inc. |
Purine L-nucleosides, analogs and uses thereof
|
|
SK284054B6
(sk)
|
1996-10-16 |
2004-08-03 |
Icn Pharmaceuticals, Inc. |
Substituované triazolové nukleozidy, farmaceutický prostriedok s ich obsahom a ich použitie
|
|
GB9708611D0
(en)
|
1997-04-28 |
1997-06-18 |
Univ Cardiff |
Chemical compounds
|
|
EP1015469B2
(en)
|
1997-09-12 |
2015-11-18 |
Exiqon A/S |
Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
|
|
EA200700564A1
(ru)
|
1998-02-25 |
2007-08-31 |
Эмори Юниверсити |
2`-фторнуклеозиды
|
|
US20030203862A1
(en)
|
1998-03-26 |
2003-10-30 |
Miraglia Loren J. |
Antisense modulation of MDM2 expression
|
|
US6833361B2
(en)
|
1998-05-26 |
2004-12-21 |
Ribapharm, Inc. |
Nucleosides having bicyclic sugar moiety
|
|
WO1999061583A2
(en)
|
1998-05-28 |
1999-12-02 |
Incara Pharmaceuticals Corp. |
Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
|
|
GB9821058D0
(en)
|
1998-09-28 |
1998-11-18 |
Univ Cardiff |
Chemical compound
|
|
DE19855963A1
(de)
|
1998-12-04 |
2000-06-08 |
Herbert Schott |
Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung
|
|
US6432975B1
(en)
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
PT1150988E
(pt)
|
1999-02-12 |
2003-10-31 |
Glaxo Group Ltd |
Esteres fosforamidato e mono-, di- e tri-fosfato de (1r,cis)-4- (6-amino-9h-purin-9-il)-2-ciclopenteno-1-metanol como agentes antivirais
|
|
ATE356824T1
(de)
|
1999-05-04 |
2007-04-15 |
Santaris Pharma As |
L-ribo-lna analoge
|
|
CA2389745C
(en)
|
1999-11-04 |
2010-03-23 |
Shire Biochem Inc. |
Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
|
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
|
SK11922002A3
(sk)
|
2000-02-18 |
2003-06-03 |
Shire Biochem Inc. |
Použitie analógov nukleozidov na liečenie alebo prevenciu infekcií spôsobených flavivírusom
|
|
JP2003532643A
(ja)
|
2000-04-13 |
2003-11-05 |
フアーマセツト・リミテツド |
肝炎ウイルス感染症を治療するための３’−または２’−ヒドロキシメチル置換ヌクレオシド誘導体
|
|
GB0009486D0
(en)
|
2000-04-17 |
2000-06-07 |
Univ Cardiff |
Chemical compounds
|
|
GB0011203D0
(en)
|
2000-05-09 |
2000-06-28 |
Univ Cardiff |
Chemical compounds
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
PL359169A1
(en)
|
2000-05-26 |
2004-08-23 |
Idenix (Cayman) Limited |
Methods and compositions for treating flaviviruses and pestiviruses
|
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
|
GB0019124D0
(en)
|
2000-08-03 |
2000-09-27 |
Pfizer |
Novel process
|
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
|
CN1133642C
(zh)
|
2000-10-09 |
2004-01-07 |
清华大学 |
核苷5’-硫代磷酰氨基酸酯化合物
|
|
KR20090089922A
(ko)
|
2000-10-18 |
2009-08-24 |
파마셋 인코포레이티드 |
바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드
|
|
JP2005502580A
(ja)
|
2000-12-15 |
2005-01-27 |
フアーマセツト・リミテツド |
フラビウィルス感染治療用抗ウィルス薬
|
|
US8481712B2
(en)
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
MXPA03006514A
(es)
|
2001-01-22 |
2004-12-02 |
Merck & Co Inc |
Derivados de nucleosidos como inhibidores de polimerasa de acido ribonucleico viral dependiente de acido ribonucleico.
|
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
RU2003129164A
(ru)
|
2001-03-01 |
2005-03-20 |
Фармассет Лтд. (Bb) |
Способ синтеза 2`,3`-дидезокси-2`,3`-дидегидронуклеозидов
|
|
GB0112617D0
(en)
|
2001-05-23 |
2001-07-18 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
EP1404694A1
(en)
|
2001-06-21 |
2004-04-07 |
Glaxo Group Limited |
Nucleoside compounds in hcv
|
|
US6962991B2
(en)
|
2001-09-12 |
2005-11-08 |
Epoch Biosciences, Inc. |
Process for the synthesis of pyrazolopyrimidines
|
|
WO2003026675A1
(en)
|
2001-09-28 |
2003-04-03 |
Idenix (Cayman) Limited |
Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside
|
|
AU2002330154A1
(en)
|
2001-09-28 |
2003-04-07 |
Centre National De La Recherche Scientifique |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
|
WO2003039523A2
(en)
|
2001-11-05 |
2003-05-15 |
Exiqon A/S |
OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
|
|
AT411065B
(de)
|
2001-12-27 |
2003-09-25 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur herstellung von heterocyclischen (r)- und (s)-cyanhydrinen
|
|
US7323453B2
(en)
|
2002-02-13 |
2008-01-29 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
|
US20120041184A1
(en)
|
2002-02-20 |
2012-02-16 |
Leonid Beigelman |
RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
WO2003073989A2
(en)
|
2002-02-28 |
2003-09-12 |
Biota, Inc. |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
|
US6800751B2
(en)
|
2002-04-11 |
2004-10-05 |
Isis Pharmaceuticals, Inc. |
Reagent and process for protecting nucleoside hydroxyl groups
|
|
WO2003087119A1
(en)
|
2002-04-12 |
2003-10-23 |
Achillion Pharmaceuticals, Inc. |
METHOD FOR SYNTHESIZING β-L-FLUORO-2´,3´DIDEHYDROCYTIDINE (β-L-FD4C)
|
|
US20040014108A1
(en)
|
2002-05-24 |
2004-01-22 |
Eldrup Anne B. |
Oligonucleotides having modified nucleoside units
|
|
WO2003099840A1
(en)
|
2002-05-24 |
2003-12-04 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
|
WO2003105770A2
(en)
|
2002-06-17 |
2003-12-24 |
Merck & Co., Inc. |
Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
AU2003269890A1
(en)
|
2002-06-21 |
2004-01-06 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
US20060234962A1
(en)
|
2002-06-27 |
2006-10-19 |
Olsen David B |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
CN101172993A
(zh)
|
2002-06-28 |
2008-05-07 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
|
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
KR20050035194A
(ko)
|
2002-06-28 |
2005-04-15 |
이데닉스 (케이만) 리미티드 |
플라비비리다에 감염 치료용 2'-ｃ-메틸-3'-ｏ-ｌ-발린에스테르 리보푸라노실 사이티딘
|
|
AU2003247084B9
(en)
|
2002-06-28 |
2018-07-26 |
Centre National De La Recherche Scientifique |
Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections
|
|
EP1556399A4
(en)
|
2002-07-16 |
2007-09-26 |
Merck & Co Inc |
Nucleoside derivatives as inhibitors of RNA-dependent viral RNA polymerase
|
|
WO2004009020A2
(en)
|
2002-07-24 |
2004-01-29 |
Merck & Co., Inc. |
Pyrrolopyrimidine thionucleoside analogs as antivirals
|
|
US20040067877A1
(en)
|
2002-08-01 |
2004-04-08 |
Schinazi Raymond F. |
2', 3'-Dideoxynucleoside analogues for the treatment or prevention of Flaviviridae infections
|
|
AU2003259735A1
(en)
|
2002-08-08 |
2004-02-25 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
|
WO2004037159A2
(en)
|
2002-10-23 |
2004-05-06 |
Obetherapy Biotechnology |
Compounds, compositions and methods for modulating fat metabolism
|
|
US20040229840A1
(en)
|
2002-10-29 |
2004-11-18 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
AU2003298658A1
(en)
|
2002-11-15 |
2004-06-15 |
Idenix (Cayman) Limited |
2'-branched nucleosides and flaviviridae mutation
|
|
TWI332507B
(en)
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
|
US7393954B2
(en)
|
2002-12-12 |
2008-07-01 |
Reliable Biopharmaceutical Corporation |
Process for the production of pentostatin aglycone and pentostatin
|
|
US7598373B2
(en)
|
2002-12-12 |
2009-10-06 |
Idenix Pharmaceuticals, Inc. |
Process for the production of 2-C-methyl-D-ribonolactone
|
|
AR043006A1
(es)
|
2003-02-12 |
2005-07-13 |
Merck & Co Inc |
Proceso para preparar ribonucleosidos ramificados
|
|
WO2004080466A1
(en)
|
2003-03-07 |
2004-09-23 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
|
WO2004089294A2
(en)
|
2003-04-04 |
2004-10-21 |
Incyte Corporation |
Compositions, methods and kits relating to her-2 cleavage
|
|
WO2004091499A2
(en)
|
2003-04-09 |
2004-10-28 |
Neose Technologies, Inc. |
Intracellular formation of peptide conjugates
|
|
RU2356896C2
(ru)
|
2003-04-16 |
2009-05-27 |
Ф.Хоффманн-Ля Рош Аг |
Производные хиназолина
|
|
WO2004096285A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-infective phosphonate conjugates
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
SG182849A1
(en)
|
2003-04-25 |
2012-08-30 |
Gilead Sciences Inc |
Antiviral phosphonate analogs
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
|
WO2005020884A2
(en)
|
2003-05-14 |
2005-03-10 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
|
RU2358979C2
(ru)
|
2003-05-30 |
2009-06-20 |
Фармассет, Инк. |
Модифицированные фторированные аналоги нуклеозида
|
|
EP1644479A4
(en)
|
2003-06-16 |
2008-04-23 |
Mark W Grinstaff |
FUNCTIONAL SYNTHETIC MOLECULES AND MACROMOLECULES FOR GENERAL FEEDING
|
|
KR20060026426A
(ko)
|
2003-06-19 |
2006-03-23 |
에프. 호프만-라 로슈 아게 |
4'-아지도 뉴클레오사이드 유도체의 제조 방법
|
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
|
ATE478886T1
(de)
|
2003-07-25 |
2010-09-15 |
Idenix Pharmaceuticals Inc |
Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c
|
|
WO2005021568A2
(en)
|
2003-08-27 |
2005-03-10 |
Biota, Inc. |
Novel tricyclic nucleosides or nucleotides as therapeutic agents
|
|
CA2542077A1
(en)
|
2003-10-08 |
2005-04-21 |
President And Fellows Of Harvard College |
Pyrovalerone analogs and therapeutic uses thereof
|
|
GB0401088D0
(en)
|
2004-01-19 |
2004-02-18 |
Univ Cardiff |
Phosphoramidate derivatives
|
|
US7741334B2
(en)
|
2004-04-01 |
2010-06-22 |
Achillion Pharmaceuticals, Inc. |
Low dose therapy for treating viral infections
|
|
WO2005123087A2
(en)
|
2004-06-15 |
2005-12-29 |
Merck & Co., Inc. |
C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
|
|
US20060040944A1
(en)
|
2004-06-23 |
2006-02-23 |
Gilles Gosselin |
5-Aza-7-deazapurine derivatives for treating Flaviviridae
|
|
US20070265222A1
(en)
|
2004-06-24 |
2007-11-15 |
Maccoss Malcolm |
Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
|
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
|
PT2258376T
(pt)
|
2004-07-27 |
2019-05-31 |
Gilead Sciences Inc |
Análogos fosfonatados de compostos inibidores do vih
|
|
ES2327252T3
(es)
|
2004-08-23 |
2009-10-27 |
F. Hoffmann-La Roche Ag |
4'-azido nucleosidos antivirales.
|
|
EP1802315A2
(en)
|
2004-10-19 |
2007-07-04 |
Achillion Pharmaceuticals, Inc. |
Combination therapy for treating viral infections
|
|
AU2005317081A1
(en)
|
2004-10-21 |
2006-06-22 |
Merck & Co., Inc. |
Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of RNA-dependent RNA viral infection
|
|
EP1827460A4
(en)
|
2004-12-09 |
2012-03-14 |
Univ Minnesota |
NUCLEOSIDE WITH ANTIVIRAL AND ANTI-CANCER EFFECT
|
|
WO2006063717A2
(en)
|
2004-12-16 |
2006-06-22 |
Febit Biotech Gmbh |
Polymerase-independent analysis of the sequence of polynucleotides
|
|
HRP20070435A9
(en)
|
2005-02-28 |
2008-09-30 |
Genelabs Technologies |
Tricyclic-nucleoside compounds for treating viral infections
|
|
AU2006222563A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
|
US20100279974A1
(en)
|
2005-03-09 |
2010-11-04 |
Claire Pierra |
Nucleosides With Non-Natural Bases as Anti-Viral Agents
|
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
|
EP2805719A1
(en)
|
2005-03-30 |
2014-11-26 |
Glaxosmithkline LLC |
Nicotinamide riboside and analogues thereof
|
|
WO2006116557A1
(en)
|
2005-04-25 |
2006-11-02 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
|
WO2006116512A1
(en)
|
2005-04-26 |
2006-11-02 |
The Board Of Trustees Of The University Of Illinois, Urbana, Il |
Nucleoside compounds and methods of use thereof
|
|
WO2007027248A2
(en)
|
2005-05-16 |
2007-03-08 |
Valeant Research & Development |
3', 5' - cyclic nucleoside analogues for treatment of hcv
|
|
CA2618560A1
(en)
|
2005-08-09 |
2007-02-22 |
Merck & Co., Inc. |
Ribonucleoside cyclic acetal derivatives for the treatment of rna-dependent rna viral infection
|
|
EP1915053A2
(en)
|
2005-08-12 |
2008-04-30 |
Merck & Co., Inc. |
Novel 2'-c-methyl and 4'-c-methyl nucleoside derivatives
|
|
CN101287472B
(zh)
|
2005-08-15 |
2011-10-12 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒的4'-取代前核苷酸的氨基磷酸酯类化合物
|
|
EA200800932A1
(ru)
|
2005-09-26 |
2008-10-30 |
Фармассет, Инк. |
Модифицированные 4`-нуклеозиды в качестве противовирусных агентов
|
|
BRPI0619563A2
(pt)
|
2005-12-09 |
2011-10-04 |
Pharmasset Inc |
nucleosìdeos antivirais
|
|
US7781576B2
(en)
|
2005-12-23 |
2010-08-24 |
Idenix Pharmaceuticals, Inc. |
Process for preparing a synthetic intermediate for preparation of branched nucleosides
|
|
EP1987050A2
(en)
|
2006-02-14 |
2008-11-05 |
Merck & Co., Inc. |
Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
|
|
EP2002005A4
(en)
|
2006-03-17 |
2009-12-09 |
Univ Mcgill |
IDENTIFICATION OF CRMP4 AS A CONVERGENCE REGULATOR OF AXON EXCEPTIONAL INHIBITION
|
|
CN101410407A
(zh)
|
2006-04-03 |
2009-04-15 |
阿斯利康(瑞典)有限公司 |
取代腺嘌呤及其应用
|
|
CN101460488A
(zh)
|
2006-04-04 |
2009-06-17 |
弗·哈夫曼-拉罗切有限公司 |
用于hcv治疗的3’,5’-二-o-酰化核苷
|
|
WO2008005542A2
(en)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc., |
Antiviral phosphinate compounds
|
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
|
HRP20110193T1
(hr)
|
2006-10-10 |
2011-05-31 |
Medivir Ab |
Inhibitor hcv nukleozida
|
|
WO2008045419A1
(en)
|
2006-10-10 |
2008-04-17 |
Pharmasset, Inc. |
Preparation of nucleosides ribofuranosyl pyrimidines
|
|
EP2077850A2
(en)
|
2006-10-31 |
2009-07-15 |
Achillion Pharmaceuticals, Inc. |
Elvucitabine pharmaceutical compositions
|
|
GB0623493D0
(en)
|
2006-11-24 |
2007-01-03 |
Univ Cardiff |
Chemical compounds
|
|
DE602007008616D1
(de)
|
2006-12-11 |
2010-09-30 |
Hoffmann La Roche |
Verfahren zur herstellung von 4'-azidocytidinderivaten
|
|
JP2010513484A
(ja)
|
2006-12-20 |
2010-04-30 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Ｒｎａ依存性ｒｎａウイルス感染治療用ヌクレオシド環状ホスホロアミデート
|
|
US7951789B2
(en)
|
2006-12-28 |
2011-05-31 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
WO2008083465A1
(en)
|
2007-01-08 |
2008-07-17 |
University Health Network |
Pyrimidine derivatives as anticancer agents
|
|
WO2008089439A2
(en)
|
2007-01-18 |
2008-07-24 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for enhancing lifespan involving sirtuin-modulating compounds and chalcogenides
|
|
US20080207554A1
(en)
|
2007-01-31 |
2008-08-28 |
Alios Biopharma, Inc. |
2-5A Analogs and their Methods of Use
|
|
WO2008100447A2
(en)
|
2007-02-09 |
2008-08-21 |
Gilead Sciences, Inc. |
Nucleoside analogs for antiviral treatment
|
|
JP2008214305A
(ja)
|
2007-03-07 |
2008-09-18 |
Kotobuki Seiyaku Kk |
置換アミン誘導体及びこれを有効成分とする医薬組成物
|
|
WO2008117047A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
WO2008127613A1
(en)
|
2007-04-11 |
2008-10-23 |
Scynexis, Inc. |
New pharmaceutical compositions
|
|
EP1980568A1
(de)
|
2007-04-13 |
2008-10-15 |
Eberhard Karls Universität Tübingen |
Ethinylierte Heterodinucleosidphosphatanaloga, Verfahren zu deren Herstellung und deren Verwendung
|
|
US20100279969A1
(en)
|
2007-05-14 |
2010-11-04 |
Rfs Pharma, Llc |
Azido purine nucleosides for treatment of viral infections
|
|
SI2014771T1
(sl)
|
2007-06-25 |
2015-04-30 |
Anadys Pharmaceuticals, Inc. |
Kontinuiran postopek encimske hidrolize
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
EP2019100A1
(en)
|
2007-07-19 |
2009-01-28 |
Santhera Pharmaceuticals (Schweiz) AG |
Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
|
|
US20090048189A1
(en)
|
2007-08-15 |
2009-02-19 |
Genelabs Technologies, Inc. |
Tricyclic-nucleoside compounds for treating viral infections
|
|
US20090076062A1
(en)
|
2007-09-13 |
2009-03-19 |
Juergen Klaus Maibaum |
Organic Compounds
|
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
|
WO2009058800A2
(en)
|
2007-10-29 |
2009-05-07 |
President And Fellows Of Harvard College |
Synthesis of nucleosides
|
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
|
US8293720B2
(en)
|
2007-12-20 |
2012-10-23 |
Dogwood Pharmaceuticals, Inc. |
Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
|
US20090181921A1
(en)
|
2007-12-21 |
2009-07-16 |
Alios Biopharma Inc. |
2-5a analogs and their methods of use
|
|
WO2009086192A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma, Inc. |
Biodegradable phosphate protected nucleotide derivatives and their use as cancer, anti viral and anti parasitic agents
|
|
EP2252612B1
(en)
|
2008-02-22 |
2012-03-28 |
Irm Llc |
Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
|
|
KR101806314B1
(ko)
|
2008-04-03 |
2017-12-07 |
스프링 뱅크 파마슈티칼스, 인크. |
바이러스 감염증을 치료하기 위한 조성물 및 방법
|
|
EP3042660A3
(en)
|
2008-04-15 |
2016-10-26 |
RFS Pharma, LLC. |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
|
PL2280973T3
(pl)
|
2008-04-23 |
2013-05-31 |
Gilead Sciences Inc |
Analogi karba-nukleozydowe do leczenia przeciwwirusowego
|
|
US8173621B2
(en)
*
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
KR20110065440A
(ko)
|
2008-07-02 |
2011-06-15 |
아이데닉스 파마슈티칼스, 인코포레이티드 |
바이러스 감염의 치료를 위한 화합물 및 제약 조성물
|
|
EP2313102A2
(en)
|
2008-07-03 |
2011-04-27 |
Biota Scientific Management |
Bycyclic nucleosides and nucleotides as therapeutic agents
|
|
GB0815968D0
(en)
|
2008-09-03 |
2008-10-08 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
|
US20110171192A1
(en)
|
2008-09-05 |
2011-07-14 |
Hiroshi Tomiyama |
Substituted amine derivative and medicinal composition comprising same as the active ingredient
|
|
WO2010039548A2
(en)
|
2008-09-23 |
2010-04-08 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
|
PA8852101A1
(es)
|
2008-12-08 |
2010-07-27 |
Medivir Ab |
Nucleótidos uracil ciclopropílicos
|
|
AR074897A1
(es)
|
2008-12-23 |
2011-02-23 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
|
CL2009002206A1
(es)
|
2008-12-23 |
2011-08-26 |
Gilead Pharmasset Llc |
Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
|
|
MX2011006890A
(es)
|
2008-12-23 |
2011-07-20 |
Pharmasset Inc |
Analogos de nucleosidos.
|
|
BRPI1004575A2
(pt)
|
2009-01-09 |
2016-04-05 |
Inhibitex Inc |
composto, composição farmacêutica, método de tratamento de infecções virais, método de separação dos diaestereômeros de fósforo
|
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
|
CA2751458C
(en)
|
2009-02-06 |
2018-06-05 |
Rfs Pharma, Llc |
Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
|
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
|
BRPI1013643A2
(pt)
|
2009-02-10 |
2016-04-19 |
Gilead Sciences Inc |
análogos de carba-nucleosídeo para tratamento antiviral
|
|
WO2010108140A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Substituted nucleoside and nucleotide analogs
|
|
US20100240604A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Protected nucleotide analogs
|
|
JO3027B1
(ar)
|
2009-05-14 |
2016-09-05 |
Janssen Products Lp |
نيوكليوسيدات يوراسيل سبيرواوكسيتان
|
|
WO2010135520A1
(en)
|
2009-05-20 |
2010-11-25 |
Chimerix, Inc. |
Compounds, compositions and methods for treating viral infection
|
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
EP2264169A1
(en)
|
2009-06-15 |
2010-12-22 |
Qiagen GmbH |
Modified siNA
|
|
US20100331397A1
(en)
|
2009-06-24 |
2010-12-30 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
|
US8728725B2
(en)
|
2009-07-06 |
2014-05-20 |
Trilink Biotechnologies |
Chemically modified ligase cofactors, donors and acceptors
|
|
US8927513B2
(en)
|
2009-07-07 |
2015-01-06 |
Alnylam Pharmaceuticals, Inc. |
5′ phosphate mimics
|
|
TW201111378A
(en)
|
2009-09-11 |
2011-04-01 |
Bayer Schering Pharma Ag |
Substituted (heteroarylmethyl) thiohydantoins
|
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
|
US20100077085A1
(en)
|
2009-09-23 |
2010-03-25 |
Joseph Chyam Cohen |
Systems and method for configuring display resolution in a terminal server environment
|
|
RU2553656C2
(ru)
|
2009-09-29 |
2015-06-20 |
ЯНССЕН ПРОДАКТС, Эл.Пи. |
Фосфорамидатные производные нуклеозидов
|
|
US20150018301A1
(en)
|
2009-11-06 |
2015-01-15 |
The Johns Hopkins University |
LRRK-2-Mediated Neuronal Toxicity
|
|
KR101840479B1
(ko)
|
2009-11-16 |
2018-03-20 |
유니버시티 오브 조지아 리서치 파운데이션, 인코포레이티드 |
바이러스 감염 치료를 위한 ２＇―플루오로―６＇―메틸렌 카보사이클릭 뉴클레오사이드 및 방법
|
|
US8816074B2
(en)
|
2009-11-16 |
2014-08-26 |
University of Georgia Foundation, Inc. |
2′-fluoro-6′-methylene carbocyclic nucleosides and methods of treating viral infections
|
|
KR101384389B1
(ko)
|
2010-01-28 |
2014-04-10 |
에프. 호프만-라 로슈 아게 |
항-ｈｃｖ 화합물로서의 4''-아지도-뉴클레오시드
|
|
WO2011109037A1
(en)
|
2010-03-04 |
2011-09-09 |
Enanta Pharmaceuticals, Inc. |
Combination pharmaceutical agents as inhibitors of hcv replication
|
|
US20130137728A1
(en)
|
2010-03-24 |
2013-05-30 |
MUSC Foundation for Research and Development |
Compositions and Methods for the Treatment of Degenerative Diseases
|
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
|
AP2012006535A0
(en)
|
2010-03-31 |
2012-10-31 |
Gilead Pharmasset Llc |
Stereoselective synthesis of phosphorous containing actives
|
|
TWI515000B
(zh)
|
2010-04-01 |
2016-01-01 |
伊迪尼克製藥公司 |
用於治療病毒感染之化合物及醫藥組合物
|
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
|
FR2960234B1
(fr)
|
2010-05-18 |
2013-11-01 |
Inst Francais Du Petrole |
Procede de dimerisation de l'ethylene en butene-1 utilisant une composition comprenant un complexe a base de titane et un ligand alcoxy fonctionnalise par un hetero-atome.
|
|
FR2960235B1
(fr)
|
2010-05-18 |
2013-11-01 |
Inst Francais Du Petrole |
Procede d'oligomerisation des olefines utilisant une composition comprenant un complexe organometallique contenant un ligand alcoxy fonctionnalise par un hetero-atome.
|
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
|
US20110306541A1
(en)
|
2010-06-10 |
2011-12-15 |
Gilead Sciences, Inc. |
Methods for treating hcv
|
|
EA025311B1
(ru)
|
2010-07-19 |
2016-12-30 |
Гайлид Сайэнсиз, Инк. |
Способы получения диастереомерно чистых фосфорамидатных пролекарств
|
|
PT2595980E
(pt)
|
2010-07-22 |
2014-11-27 |
Gilead Sciences Inc |
Métodos e compostos para tratar infeções pelo vírus da família paramyxoviridae
|
|
WO2012025857A1
(en)
|
2010-08-23 |
2012-03-01 |
Hetero Research Foundation |
Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors
|
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
吉李德科學股份有限公司 |
用於抗病毒治療之２’－氟取代之碳－核苷類似物
|
|
AU2011305652B2
(en)
|
2010-09-22 |
2016-10-20 |
Janssen Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
|
US20120070411A1
(en)
|
2010-09-22 |
2012-03-22 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
|
WO2012040127A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
|
WO2012041965A1
(en)
|
2010-09-29 |
2012-04-05 |
Universidad Nacional De Quilmes |
Process for producing dialkylphosphotriesters of nucleosides by enzymatic transesterification and deprotection thereof for producing nucleoside monophosphates
|
|
WO2012048013A2
(en)
|
2010-10-06 |
2012-04-12 |
Inhibitex, Inc. |
Phosphorodiamidate derivatives of guanosine nucleoside compounds for treatment of viral injections
|
|
WO2012062869A1
(en)
|
2010-11-10 |
2012-05-18 |
Janssen Products, Lp |
Uracyl spirooxetane nucleoside phosphoramidates
|
|
PL2638054T3
(pl)
|
2010-11-10 |
2015-05-29 |
Janssen Products Lp |
Fosforoamidany nukleozydów uracylo-spirooksetanowych
|
|
WO2012074547A2
(en)
|
2010-11-29 |
2012-06-07 |
New York University |
STEROID COMPOUNDS AS RORγt MODULATORS AND USES THEREOF
|
|
ES2716158T3
(es)
|
2010-11-30 |
2019-06-10 |
Gilead Pharmasset Llc |
2'-spiro-nucleótidos para el tratamiento de hepatitis C
|
|
TW201306841A
(zh)
|
2010-12-20 |
2013-02-16 |
Gilead Sciences Inc |
治療ｃ型肝炎病毒（ｈｃｖ）之方法
|
|
US8772474B2
(en)
|
2010-12-22 |
2014-07-08 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
|
WO2012092484A2
(en)
|
2010-12-29 |
2012-07-05 |
Inhibitex, Inc. |
Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
|
|
US9095599B2
(en)
|
2011-01-03 |
2015-08-04 |
Nanjing Molecular Research, Inc. |
O-(substituted benzyl) phosphoramidate compounds and therapeutic use
|
|
WO2012099630A1
(en)
|
2011-01-20 |
2012-07-26 |
University Of Rochester |
Compositions and methods for treating or preventing a retrovirus infection
|
|
CN103717222A
(zh)
|
2011-02-24 |
2014-04-09 |
浙江大学 |
桥二硫二氧代哌嗪及其在治疗癌症方面的用途
|
|
US9085599B2
(en)
|
2011-03-16 |
2015-07-21 |
Enanta Pharmaceuticals, Inc. |
2′allene-substituted nucleoside derivatives
|
|
US9243025B2
(en)
|
2011-03-31 |
2016-01-26 |
Idenix Pharmaceuticals, Llc |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
EP2697241B1
(en)
|
2011-04-13 |
2019-06-12 |
Gilead Sciences, Inc. |
1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment
|
|
EP2697242B1
(en)
|
2011-04-13 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
WO2012142085A1
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
EP2696679B1
(en)
|
2011-04-13 |
2017-08-02 |
Merck Sharp & Dohme Corp. |
2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
WO2012158811A2
(en)
|
2011-05-19 |
2012-11-22 |
Rfs Pharma, Llc |
Purine monophosphate prodrugs for treatment of viral infections
|
|
WO2012167133A2
(en)
|
2011-06-01 |
2012-12-06 |
The Regents Of The University Of California |
Inhibitors of anandamide transport and their therapeutic uses
|
|
FR2977586B1
(fr)
|
2011-07-08 |
2013-07-12 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
|
WO2013009737A1
(en)
|
2011-07-13 |
2013-01-17 |
Merck Sharp & Dohme Corp. |
5'-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases
|
|
WO2013009735A1
(en)
|
2011-07-13 |
2013-01-17 |
Merck Sharp & Dohme Corp. |
5'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
WO2013013009A2
(en)
|
2011-07-19 |
2013-01-24 |
Nanjing Molecular Research, Inc. |
2',3'-DIDEOXY-2'-α-FLUORO-2'-β-C-METHYLNUCLEOSIDES AND PRODRUGS THEREOF
|
|
AU2012290089B2
(en)
|
2011-08-01 |
2016-09-29 |
Mbc Pharma, Inc. |
Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
|
|
AU2012308900A1
(en)
|
2011-09-12 |
2013-05-09 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
US8575119B2
(en)
|
2011-09-23 |
2013-11-05 |
Enanta Pharmaceuticals, Inc. |
2′-chloroacetylenyl substituted nucleoside derivatives
|
|
AR089650A1
(es)
|
2011-10-14 |
2014-09-10 |
Idenix Pharmaceuticals Inc |
Fosfatos 3,5-ciclicos sustituidos de compuestos de nucleotido de purina y composiciones farmaceuticas para el tratamiento de infecciones virales
|
|
MX370976B
(es)
|
2011-11-11 |
2020-01-10 |
Gilead Apollo Llc |
Inhibidores de acetil coa carboxilasa (acc) y usos de los mismos.
|
|
CN103102345B
(zh)
|
2011-11-14 |
2015-06-03 |
广东东阳光药业有限公司 |
氨基喹唑啉类衍生物及其盐和使用方法
|
|
FR2982858B1
(fr)
|
2011-11-18 |
2013-11-29 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
|
FR2984322B1
(fr)
|
2011-12-16 |
2013-12-20 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
|
EA024297B1
(ru)
|
2011-12-20 |
2016-09-30 |
Рибосайенс Ллк |
2',4'-дифтор-2'-метилзамещенные нуклеозидные производные в качестве ингибиторов репликации рнк вируса гепатита с
|
|
IN2014CN04530A
(es)
|
2011-12-20 |
2015-09-11 |
Hoffmann La Roche |
|
|
KR102072041B1
(ko)
|
2011-12-22 |
2020-01-31 |
앨리오스 바이오파마 인크. |
치환된 뉴클레오사이드, 뉴클레오타이드 및 그의 유사체
|
|
EP2794630A4
(en)
|
2011-12-22 |
2015-04-01 |
Alios Biopharma Inc |
SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
|
|
WO2013106344A1
(en)
|
2012-01-12 |
2013-07-18 |
Ligand Pharmaceuticals, Inc. |
2 '-c-methyl nucleosides containing a cyclic phosphate diester of 1, 3-propanediol (2-oxo-[1, 3, 2]-dioxaphosphorinane) at position 5'
|
|
WO2013138210A1
(en)
|
2012-03-14 |
2013-09-19 |
Ning Xi |
Substituted cyclic compounds and methods of use
|
|
HK1203513A1
(en)
|
2012-03-21 |
2015-10-30 |
艾丽奥斯生物制药有限公司 |
Methods of preparing substituted nucleotide analogs
|
|
WO2013142159A1
(en)
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
NZ631601A
(en)
|
2012-03-21 |
2016-06-24 |
Alios Biopharma Inc |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
|
SI2827875T1
(sl)
|
2012-03-21 |
2019-04-30 |
Alios Biopharma, Inc. |
Substituirani nukleozidi, nukleotidi in njihovi analogi
|
|
NZ630805A
(en)
|
2012-03-22 |
2016-01-29 |
Alios Biopharma Inc |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
US9809616B2
(en)
|
2012-10-29 |
2017-11-07 |
Emory University |
Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer
|
|
MD20140134A2
(ro)
|
2012-05-22 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
Compuşi ai D-aminoacizilor pentru tratamentul bolilor hepatice
|
|
WO2013177195A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphate prodrugs for hcv infection
|
|
EP2852604B1
(en)
|
2012-05-22 |
2017-04-12 |
Idenix Pharmaceuticals LLC |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
|
PT2861611T
(pt)
|
2012-05-25 |
2016-10-11 |
Janssen Sciences Ireland Uc |
Nucleósidos de espirooxetano de uracilo
|
|
EP2870169A1
(en)
|
2012-07-03 |
2015-05-13 |
Bristol-Myers Squibb Company |
Process for preparing diastereomerically enriched phosphoramidate derivatives of nucleoside compounds for treatment of viral infections
|
|
WO2014047117A1
(en)
|
2012-09-18 |
2014-03-27 |
Bristol-Myers Squibb Company |
Process for preparing phosphoramidate derivatives of nucleoside compounds for treatment of viral infections
|
|
WO2014048939A1
(en)
|
2012-09-26 |
2014-04-03 |
F. Hoffmann-La Roche Ag |
Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
|
MX362855B
(es)
|
2012-09-26 |
2019-02-20 |
Merck Patent Gmbh |
Derivados de quinazolinona como inhidores poli (adp-ribosa) polimerasa (parp).
|
|
WO2014052638A1
(en)
|
2012-09-27 |
2014-04-03 |
Idenix Pharmaceuticals, Inc. |
Esters and malonates of sate prodrugs
|
|
ES2674980T3
(es)
|
2012-10-08 |
2018-07-05 |
Idenix Pharmaceuticals Llc |
Análogos de 2'-cloro nucleósidos para infección por VHC
|
|
AR092959A1
(es)
|
2012-10-17 |
2015-05-06 |
Merck Sharp & Dohme |
Derivados de nucleosidos 2-metil sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
|
|
EP2909209B1
(en)
|
2012-10-17 |
2022-08-03 |
Merck Sharp & Dohme LLC |
2'-cyano substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases
|
|
EP2909210A4
(en)
|
2012-10-17 |
2016-04-06 |
Merck Sharp & Dohme |
2'-DISUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHOD FOR THE USE THEREOF FOR THE TREATMENT OF VIRUS DISEASES
|
|
EP2909223B1
(en)
|
2012-10-19 |
2017-03-22 |
Idenix Pharmaceuticals LLC |
Dinucleotide compounds for hcv infection
|
|
WO2014066239A1
(en)
|
2012-10-22 |
2014-05-01 |
Idenix Pharmaceuticals, Inc. |
2',4'-bridged nucleosides for hcv infection
|
|
WO2014078427A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-alanine ester of rp-nucleoside analog
|
|
WO2014078436A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-alanine ester of sp-nucleoside analog
|
|
US20140205566A1
(en)
|
2012-11-30 |
2014-07-24 |
Novartis Ag |
Cyclic nucleuoside derivatives and uses thereof
|
|
US9211300B2
(en)
|
2012-12-19 |
2015-12-15 |
Idenix Pharmaceuticals Llc |
4′-fluoro nucleosides for the treatment of HCV
|
|
AU2013361193B2
(en)
|
2012-12-21 |
2018-05-24 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
US9243022B2
(en)
|
2012-12-21 |
2016-01-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
US10034893B2
(en)
|
2013-02-01 |
2018-07-31 |
Enanta Pharmaceuticals, Inc. |
5, 6-D2 uridine nucleoside/tide derivatives
|
|
WO2014124430A1
(en)
|
2013-02-11 |
2014-08-14 |
Emory University |
Nucleotide and nucleoside therapeutic compositions and uses related thereto
|
|
US20140309413A1
(en)
|
2013-03-11 |
2014-10-16 |
Vertex Pharmaceuticals Incorporated |
Methods of stereoselective synthesis of substituted nucleoside analogs
|
|
EP2970357B1
(en)
|
2013-03-13 |
2025-01-01 |
Idenix Pharmaceuticals LLC |
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
|
|
CN103848876B
(zh)
|
2013-03-25 |
2016-05-11 |
安徽贝克联合制药有限公司 |
一种核苷磷酰胺前药及其制备方法和其应用
|
|
EP2981542B1
(en)
|
2013-04-01 |
2021-09-15 |
Idenix Pharmaceuticals LLC |
2',4'-fluoro nucleosides for the treatment of hcv
|
|
TW201532606A
(zh)
|
2013-04-05 |
2015-09-01 |
Alios Biopharma Inc |
使用化合物之組合治療ｃ型肝炎病毒感染
|
|
AU2014250762A1
(en)
|
2013-04-12 |
2015-10-29 |
Achillion Pharmaceuticals, Inc. |
Highly active nucleoside derivative for the treatment of HCV
|
|
AU2014265293B2
(en)
|
2013-05-16 |
2019-07-18 |
Riboscience Llc |
4'-Fluoro-2'-methyl substituted nucleoside derivatives
|
|
AU2014302715B2
(en)
|
2013-06-26 |
2018-12-06 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
ES2952714T3
(es)
|
2013-06-26 |
2023-11-03 |
Janssen Pharmaceuticals Inc |
Nucleósidos sustituidos, nucleótidos y análogos de los mismos
|
|
TW201542581A
(zh)
|
2013-09-11 |
2015-11-16 |
艾默理大學 |
核苷酸與核苷治療組成物及其相關用途
|
|
CN105829333A
(zh)
|
2013-10-11 |
2016-08-03 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸及其类似物
|
|
WO2015061683A1
(en)
|
2013-10-25 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate and d-alanine thiophosphoramidate pronucleotides of nucleoside compounds useful for the treatment of hcv
|
|
JP2017504572A
(ja)
|
2013-11-27 |
2017-02-09 |
アイデニクス・ファーマシューティカルズ・エルエルシー |
肝臓癌治療のためのヌクレオチド類
|
|
CN103848877B
(zh)
|
2013-12-16 |
2016-08-24 |
安徽贝克联合制药有限公司 |
核苷环磷酸酯化合物及其制备方法和其应用
|